AREPANRIX Trademark

Trademark Overview

On Friday, February 13, 2009, a trademark application was filed for AREPANRIX with the United States Patent and Trademark Office. The USPTO has given the AREPANRIX trademark a serial number of 77670202. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, October 27, 2017. This trademark is owned by GlaxoSmithKline Biologicals S.A.. The AREPANRIX trademark is filed in the Pharmaceutical Products category with the following description:

Vaccines for the treatment and prevention of influenza
arepanrix

General Information

Serial Number77670202
Word MarkAREPANRIX
Filing DateFriday, February 13, 2009
Status710 - CANCELLED - SECTION 8
Status DateFriday, October 27, 2017
Registration Number3933238
Registration DateTuesday, March 22, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 16, 2009

Trademark Statements

Goods and ServicesVaccines for the treatment and prevention of influenza

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, October 27, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaxoSmithKline Biologicals S.A.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals S.A.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE
Party NameGlaxoSmithKline Biologicals S.A.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRixensart B-1330
BE

Trademark Events

Event DateEvent Description
Friday, October 27, 2017CANCELLED SEC. 8 (6-YR)
Tuesday, March 22, 2016COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 8, 2015TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 7, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, June 7, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 15, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 20, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 20, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 22, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, February 16, 20111(B) BASIS DELETED; PROCEED TO REGISTRATION
Tuesday, February 15, 2011NOTICE OF ALLOWANCE CANCELLED
Tuesday, February 15, 2011TEAS POST PUBLICATION AMENDMENT RECEIVED
Thursday, September 16, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 15, 2010EXTENSION 2 GRANTED
Wednesday, September 8, 2010EXTENSION 2 FILED
Wednesday, September 8, 2010TEAS EXTENSION RECEIVED
Thursday, May 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 24, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, March 23, 2010EXTENSION 1 GRANTED
Thursday, February 18, 2010EXTENSION 1 FILED
Tuesday, March 23, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 18, 2010TEAS EXTENSION RECEIVED
Saturday, October 24, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 16, 2009PUBLISHED FOR OPPOSITION
Wednesday, May 27, 2009NOTICE OF PUBLICATION
Monday, May 11, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, May 8, 2009ASSIGNED TO LIE
Friday, May 8, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 5, 2009ASSIGNED TO EXAMINER
Wednesday, February 18, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, February 18, 2009NEW APPLICATION ENTERED IN TRAM

Related Keywords

arepanrix influenza prevention treatment vaccines